SG11202012984YA - STABILITY OF VITAMIN D IN ß-HYDROXY- ß-METHYLBUTYRATE (HMB) - Google Patents

STABILITY OF VITAMIN D IN ß-HYDROXY- ß-METHYLBUTYRATE (HMB)

Info

Publication number
SG11202012984YA
SG11202012984YA SG11202012984YA SG11202012984YA SG11202012984YA SG 11202012984Y A SG11202012984Y A SG 11202012984YA SG 11202012984Y A SG11202012984Y A SG 11202012984YA SG 11202012984Y A SG11202012984Y A SG 11202012984YA SG 11202012984Y A SG11202012984Y A SG 11202012984YA
Authority
SG
Singapore
Prior art keywords
hmb
methylbutyrate
vitamin
hydroxy
stability
Prior art date
Application number
SG11202012984YA
Other languages
English (en)
Inventor
John Rathmacher
Martin Pupura
Original Assignee
Metabolic Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolic Technologies Inc filed Critical Metabolic Technologies Inc
Publication of SG11202012984YA publication Critical patent/SG11202012984YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202012984YA 2019-06-25 2019-06-25 STABILITY OF VITAMIN D IN ß-HYDROXY- ß-METHYLBUTYRATE (HMB) SG11202012984YA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2019/038948 WO2020263229A1 (fr) 2019-06-25 2019-06-25 STABILITÉ DE LA VITAMINE D DANS DU β-HYDROXY-β-MÉTHYLBUTYRATE (HMB)

Publications (1)

Publication Number Publication Date
SG11202012984YA true SG11202012984YA (en) 2021-01-28

Family

ID=74060572

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202012984YA SG11202012984YA (en) 2019-06-25 2019-06-25 STABILITY OF VITAMIN D IN ß-HYDROXY- ß-METHYLBUTYRATE (HMB)

Country Status (7)

Country Link
JP (1) JP2022545299A (fr)
KR (1) KR20220050082A (fr)
CN (1) CN113056206A (fr)
AU (1) AU2019453386A1 (fr)
CA (1) CA3105039A1 (fr)
SG (1) SG11202012984YA (fr)
WO (1) WO2020263229A1 (fr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849613B2 (en) * 2001-08-29 2005-02-01 Kedar N. Prasad Multiple antioxidant micronutrients
US20060019933A1 (en) * 2004-07-22 2006-01-26 David Boardman Process for preparing stabilized vitamin D
US20100178369A1 (en) * 2009-01-15 2010-07-15 Nicole Lee Arledge Antioxidant-stabilized concentrated fish oil
EP2672843B1 (fr) * 2011-02-07 2018-07-11 Abbott Laboratories Produits à finalité nutritionnelle comportant du bêta-hydroxy-bêta-méthylbutyrate
CN102512655B (zh) * 2011-11-30 2013-10-30 北京康比特体育科技股份有限公司 左旋肉碱组合物和制剂，及其制备方法和应用
JP6480964B2 (ja) * 2014-03-14 2019-03-13 メタボリック・テクノロジーズ，インコーポレーテッド 遊離酸形のβ−ヒドロキシ−β−メチル酪酸（ＨＭＢ）を含有する液体及び食品ならびにその製造法
EP3435969A1 (fr) * 2016-03-30 2019-02-06 Symrise AG Mélange actif

Also Published As

Publication number Publication date
KR20220050082A (ko) 2022-04-22
AU2019453386A1 (en) 2021-02-18
WO2020263229A1 (fr) 2020-12-30
CA3105039A1 (fr) 2020-12-30
CN113056206A (zh) 2021-06-29
JP2022545299A (ja) 2022-10-27

Similar Documents

Publication Publication Date Title
IL283743A (en) History of 2-Oxoquinazoline as Methionine Adenosyl Transferase 2a Inhibitors
ZA201907661B (en) Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor
IL262495B (en) History of isoquinolin-3-yl carboxamide and pharmaceutical preparations containing them
SG11202102456VA (en) High-potency vitamin c topical formulations
EP3344624B8 (fr) Inhibiteurs de tyk2 et leurs utilisations
EP3262049A4 (fr) Inhibiteurs de tyk2 et leurs utilisations
GEP20207075B (en) New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them
IL267831A (en) Substances used for healing and as nutritional supplements
ZA201801651B (en) Application of high flavonoid elite germplasm 'csr6r6-777' in breeding for functional apple
PL3139904T3 (pl) Formulacja witaminy rozpuszczalnej w tłuszczach
EP3731832A4 (fr) Forme posologique à base de cannabinoïdes
EP3380525A4 (fr) Formulations pharmaceutiques et leurs procédés d'utilisation
EP3472176A4 (fr) L'utilité de (+) épicatéchine et de leurs analogues
IL268072A (en) Methods and systems for improving the stability of electronic inhaler pre-vapor formulations
HK1252405A1 (zh) 用於減少脂肪量的β-羥基-β-甲基丁酸(HMB)的組合物和使用方法
IL285674A (en) Pharmaceutical formulations
IL269305B1 (en) Cannabinoid formulations and dosage
CA200923S (en) Footrest
EP3285768A4 (fr) Compositions pharmaceutiques comprenant du lonafarnib et du ritonavir
EP3506947A4 (fr) Formulations pharmaceutiques de régadénosone
SG11202012984YA (en) STABILITY OF VITAMIN D IN ß-HYDROXY- ß-METHYLBUTYRATE (HMB)
EP3612185A4 (fr) Compositions pharmaceutiques comprenant des dérivés de poh et procédés d'utilisation
EP3554508A4 (fr) Formulations pharmaceutiques de suvorexant
EP3836803A4 (fr) Stabilité de la vitamine d dans du beta-hydroxy-beta-méthylbutyrate (hmb)
DE112020001186A5 (de) Nahrungsergänzungsmittel